Radiofrequency Ablation Devices Market Scope And Analysis

  • Report Code : TIPRE00004752
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

Radiofrequency Ablation Devices Market Scope, Analysis, and Trends by 2031

Buy Now


Radiofrequency Ablation Devices Market Report Scope

Report Attribute Details
Market size in 2021 US$ 3.93 Billion
Market Size by 2031 US$ 12.08 Billion
Global CAGR (2023 - 2031) 12.2%
Historical Data 2021-2022
Forecast period 2023-2031
Segments Covered By Product
  • Devices
  • Disposables
By Application
  • Surgical Oncology
  • Cardiology
  • Gynecology
  • Cosmetology
  • Pain Management
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Avanos Medical Inc
  • Stryker
  • Abbott
  • Medtronic
  • Boston Scientific
  • Bard BD
  • Angiodynamic
  • Hologic
  • Articure
  • Merit medical
  • Radiofrequency Ablation Devices Market News and Recent Developments

    The radiofrequency ablation devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for radiofrequency ablation devices market:

    • AtriCure, Inc., a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, announced that it has launched the EnCompass Clamp, a part of the Isolator Synergy Ablation System in the United States. The EnCompass Clamp received FDA 510(k) clearance for ablation of cardiac tissue during cardiac surgery and is designed to make concomitant surgical ablations more efficient. (Source: ATRICURE, INC., Press Release, 2022)
    • BD (Becton, Dickinson, and Company), a leading global medical technology company, announced today it has acquired Venclose, Inc., a provider of solutions for the treatment of chronic venous insufficiency (CVI) — a disease that is the result of malfunctioning valves and can lead to varicose veins. (Source: BD, Press Release, 2021)

    Radiofrequency Ablation Devices Market Report Coverage and Deliverables

    The “Radiofrequency Ablation Devices Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Market dynamics such as drivers, restraints, and key opportunities
    • Key future trends
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
    • Detailed company profiles